Single course of high dose dexamethasone is more effective than conventional prednisolone therapy in the treatment of primary newly diagnosed immune thrombocytopenia
- PMID: 23351609
- PMCID: PMC3557140
- DOI: 10.1186/2008-2231-20-7
Single course of high dose dexamethasone is more effective than conventional prednisolone therapy in the treatment of primary newly diagnosed immune thrombocytopenia
Abstract
Introduction: Immune thrombocytopenia (ITP) is an immune disorder commonly presents as isolated thrombocytopenia. Generally corticosteroids are the main treatment of ITP. This study was designed to evaluate effectiveness of high dose dexamethasone comparing conventional corticosteroid therapy in the treatment of ITP.
Materials and methods: In a randomized prospective study, sixty adult patients with newly diagnosed primary symptomatic ITP (Platelet count < 20,000) were evaluated. Patients divided into two groups. In group A, thirty patients (mean age of 24.9 years) received Dexamethasone 40 mg/IV/daily for four days (10 mg/q6h); and then Prednisolone 1 mg/kg/day/PO with rapid tapering of prednisolone (10 mg/week). From the other hand, in group B, thirty patients (mean age of 27.2 years) were treated with Prednisolone 1 mg/kg/day/PO for four weeks, then the drug tapered weekly.
Results: All the patients in group A showed favorable response within the first seven days, 27 cases presented complete response (CR) and three cases revealed response (R). In group B, 11 cases had CR, 13 cases showed R and six cases had No response (NR). After three months, rates of CR were 80% and 23.3% in group A and B; respectively. Responses were 16.7% and 33.3%, NRs were 6.6% and 43.3% in group A and B; respectively (P < 0.0001). After 6 months, CR was 73.3% vs.16.7%, and R was 16.7% vs.36.7% and NR was 10% vs. 46.7% in group A and B; respectively (P < 0.0001). After 12 months, there was no change in response rate in group A, but in group B 53% were non responsive, 40% showed R (chronic ITP) and complete response was observed only in 6.7% (P < 0.0001). Three cases in group A and 12 cases in group B had needed splenectomy (P < 0.00002).
Conclusion: We showed that high dose dexamethasone is more effective than conventional steroid therapy in newly diagnosed ITP as initial treatment with less relapses and toxicities.
Similar articles
-
Comparison Of Efficacy Of High Dose Dexamethasone With Conventional Prednisolone In The Treatment Of Newly Diagnosed Adult Patients Of Immunthrombocytopenic Purpura.J Ayub Med Coll Abbottabad. 2022 Jul-Sep;34(3):427-430. doi: 10.55519/JAMC-03-9786. J Ayub Med Coll Abbottabad. 2022. PMID: 36377150
-
Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.Am J Hematol. 2005 Apr;78(4):275-80. doi: 10.1002/ajh.20276. Am J Hematol. 2005. PMID: 15795920
-
Anti-GPIb/IX autoantibodies are associated with poor response to dexamethasone combined with rituximab therapy in primary immune thrombocytopenia patients.Platelets. 2023 Dec;34(1):2258988. doi: 10.1080/09537104.2023.2258988. Epub 2023 Sep 18. Platelets. 2023. PMID: 37722393
-
[Diagnostic approach and treatment of immune thrombocytopenia in adults].Acta Med Croatica. 2013 Mar;67(1):3-11. Acta Med Croatica. 2013. PMID: 24279250 Review. Croatian.
-
Controversies in the treatment of immune thrombocytopenia.Curr Opin Hematol. 2016 Sep;23(5):479-85. doi: 10.1097/MOH.0000000000000270. Curr Opin Hematol. 2016. PMID: 27380558 Review.
Cited by
-
Evidence-based management of immune thrombocytopenia: ASH guideline update.Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):568-575. doi: 10.1182/asheducation-2018.1.568. Hematology Am Soc Hematol Educ Program. 2018. PMID: 30504359 Free PMC article. Review.
-
Management of immune thrombocytopenia: 2022 update of Korean experts recommendations.Blood Res. 2022 Mar 31;57(1):20-28. doi: 10.5045/br.2022.2022043. Blood Res. 2022. PMID: 35342042 Free PMC article. Review.
-
The Efficacy of High-Dose Dexamethasone vs. Other Treatments for Newly Diagnosed Immune Thrombocytopenia: A Meta-Analysis.Front Med (Lausanne). 2021 May 25;8:656792. doi: 10.3389/fmed.2021.656792. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34113634 Free PMC article.
-
Comparison of up-front treatments for newly diagnosed immune thrombocytopenia -a systematic review and network meta-analysis.Haematologica. 2018 Jan;103(1):163-171. doi: 10.3324/haematol.2017.174615. Epub 2017 Sep 29. Haematologica. 2018. PMID: 28971908 Free PMC article.
-
Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial.Blood Adv. 2024 Mar 26;8(6):1529-1540. doi: 10.1182/bloodadvances.2023010975. Blood Adv. 2024. PMID: 38231017 Free PMC article. Clinical Trial.
References
-
- Chong BH, Keng TB. Advances in the diagnosis of idiopathic thrombocytopenic purpura. Semin Hematol. 2000;3:249–260. - PubMed
LinkOut - more resources
Full Text Sources